IL2 and cancer: Pathway enrichment using Hallmark gene sets (MSigDB) revealed enrichment of key cancer hallmarks such as epithelial-to-mesenchymal transition (EMT), IL-2 STAT5 signaling, and early response to estrogen (Figure S9B).